Sign up for our free daily newsletter
YOUR PRIVACY - PLEASE READ CAREFULLY DATA PROTECTION STATEMENT
Below we explain how we will communicate with you. We set out how we use your data in our Privacy Policy.
Global City Media, and its associated brands will use the lawful basis of legitimate interests to use
the
contact details you have supplied to contact you regarding our publications, events, training,
reader
research, and other relevant information. We will always give you the option to opt out of our
marketing.
By clicking submit, you confirm that you understand and accept the Terms & Conditions and Privacy Policy
Artificial intelligence start-up Humane has launched public orders for its wearable AI Pin – a stand-alone smart assistant that attaches to clothing via a magnet. According to founders Imran Chaudhri and Bethany Bongiorno (both former Apple employees), “This is more than a launch – it’s the beginning of a new era”.
At Paris Fashion Week, the fashion community had an early glimpse of the AI Pin’s look, although not its functionality, in support of their “forward-thinking fashion” vision “that design, creativity and technology can be a huge driver and cultural force for change”.
Coperni designers Sébastien Meyer and Arnaud Vaillant adorned Naomi Campbell and other models in their autumn show with a prototype of the AI Pin. The models didn’t interact with the device, so “it was impossible to judge except on its aesthetics” and “the pin didn’t add any sort of design element to the clothes” (Wearables Resurface at the Paris Shows of 3 Fashion Brands).
What does the AI Pin do?
Humane’s demo video shows use of the AI Pin to provide nutritional advice, track health goals, purchase items from retailers, make personalised dining recommendations and listen to music, all using touch, voice, hand gestures and a “laser ink” display projected onto the palm. Access to ChatGPT is also a core feature.
In the demo, Humane’s founders tout the privacy and data security features: “It’s not always listening or always recording. In fact, it doesn’t do anything until you engage with it… The trust light indicates when its input, optical or audio sensors are active, ensuring full transparency and data security.”
These claims may be reactive to the current state of public opinion concerning AI technology, and the US Federal Trade Commission’s focus on how companies are using AI technology. Recent surveys by The Pew Research Center reveal that a substantial majority of Americans remain wary of AI generally, don’t trust AI companies to use the technology responsibly and lack confidence that the data collected by AI tools and devices will be used as originally intended. The FTC has stated that it is paying particular attention to uses that “deliberately or not, steer people unfairly or deceptively into harmful decisions in areas such as finances, health, education, housing and employment”.
Could the AI Pin be regulated as a medical device in the US?
In light of the AI Pin’s health and wellness features, it is also worth considering whether it could be subject to regulation by the US Food and Drug Administration (FDA) as a “medical device”, which is defined, with limited exceptions, to include any device that is intended to assist in the diagnosis, treatment, mitigation or cure of a disease or condition or otherwise intended to affect the structure or any function of the body. Examples of regulated personalised use devices include those intended to assist users in diagnosing insomnia or obesity, as well as those intended to help users reduce high blood pressure or reduce anxiety – all of which the FDA categorises as “disease state” conditions. Medical device manufacturers and distributors are subject to a wide range of regulatory responsibilities, including those related to labelling and advertising, reporting of adverse events, good manufacturing practices and potentially pre-market notification to the FDA, among others.
For a device like the AI Pin that claims to focus largely on “health and nutrition” information (at this stage), it is crucial to analyse which claims and features would cause the product to be actively regulated as a device, as compared to those that fall within the “general wellness product” category, and are excepted from active FDA regulation. These products include software and hardware devices that are (1) low risk (e.g. not implanted, invasive or otherwise pose safety risks), and (2) make claims related to “encouraging a healthy lifestyle” while avoiding any claims to treat, diagnose or cure a disease. For example, if the AI Pin’s claims only relate to helping users with “relaxation or stress management”, the product may not be a device, while an anxiety claim would trigger regulation. Likewise, claims to tracking exercise, promoting healthy weight management, healthy nutrition or assisting users with sleep management are appropriate general wellness claims, while any express or implied claims related to obesity, diabetes or insomnia are not.
Will the luxury community be early adopters of the AI Pin?
The collaboration with Coperni – a luxury designer brand – and starting price of $699 hint that Humane might be seeking to position the AI Pin as a luxury accessory.
But Humane isn’t the first tech company to pair up with the fashion world to debut cutting-edge wearable tech. Over a decade ago, Diane von Furstenberg introduced Google Glass via the catwalk at New York Fashion Week 2012. And the Apple Watch made its first public appearance during Paris Fashion Week in 2014 followed by a 12-page spread in the March 2015 edition of Vogue.
Whether the AI Pin will see early adoption in the luxury market remains to be seen. From our vantage point, we’ll continue to wait, watch and investigate the legal implications.
Loeb & Loeb partner Melanie J. Howard is chair of the firm’s intellectual property protection practice, chair of its luxury brands practice and deputy chair of the firm’s advanced media and technology practice. Based in Los Angeles, she can be reached at [email protected].
Kristen Klesh is a partner in Loeb & Loeb’s Washington DC office and advises clients on a broad range of Food and Drug Administration (FDA), Federal Trade Commission (FTC) and related state law regulatory compliance matters throughout all stages of the product life cycle. She can be reached at [email protected].
Email your news and story ideas to: [email protected]